Inchcape plc (FRA:IJCA)

Intra-Cellular Therapies Revenue

Inchcape had revenue of 4.32B GBP in the half year ending June 30, 2025, a decrease of -5.33%. This brings the company's revenue in the last twelve months to 8.86B, down -7.19% year-over-year. In the year 2024, Inchcape had annual revenue of 9.26B, down -1.27%.

• Revenue (ttm): 8.86B GBP
• Revenue Growth: -7.19%
• P/S Ratio: 0.28
• Revenue / Employee: 503.64K GBP
• Employees: 17,588
• Market Cap: 2.92B USD

Revenue Chart

* This company reports financials in GBP.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	9.26B	-119.00M	-1.27%
Dec 31, 2023	9.38B	1.25B	15.36%
Dec 31, 2022	8.13B	1.23B	17.85%
Dec 31, 2021	6.90B	63.10M	0.92%
Dec 31, 2020	6.84B	-2.54B	-27.10%